0.2905

2.19% -0.0065

Qualigen Therapeutics Inc (QLGN)

Panoramica Notizia Cronologia dei prezzi Forum Previsione Frazionamento azionario

Precedente Chiudi:

$0.297

Aprire:

$0.3

Volume 24 ore:

9,216

Capitalizzazione di mercato:

$1.83M

Reddito:

$4.79M

Utile/perdita netta:

$-13.42M

Rapporto P/E:

-0.0723

EPS:

-4.02

Flusso di cassa netto:

$-10.30M

1 W Prestazione:

-8.65%

1M Prestazione:

-27.56%

6M Prestazione:

-60.59%

1 anno Prestazione:

-67.63%

Intervallo 1D:

$0.2905

$0.319

Portata 52W:

$0.2831

$1.26

Qualigen Therapeutics Inc Stock (QLGN) Company Profile

Nome

Qualigen Therapeutics Inc

Settore

Healthcare (1191)

Industria

Biotechnology (688)

Telefono

760 918 9165

Indirizzo

2042 Corte Del Nogal, Carlsbad

Dipendente

Cinguettio

Prossima data di guadagno

2024-05-14

Ultimi documenti SEC

QLGN's Discussions on Twitter

Qualigen Therapeutics Inc Borsa (QLGN) Ultime notizie

Qualigen Therapeutics' Novel Direct Pan-RAS Inhibitors Presented at American Association of Cancer Research (AACR) 2024 Annual Meeting

GlobeNewswire Inc.

Qualigen Therapeutics Announces Poster Featuring Positive Early Clinical Experience with QN-302, a Novel First-in-Class G-Quadruplex Experimental Anti-Cancer Drug, at the American Association of Cancer Research (AACR) 2024 Annual Meeting

GlobeNewswire Inc.

Why Richardson Electronics Shares Are Trading Lower By 13%; Here Are 20 Stocks Moving Premarket

Benzinga

Qualigen Therapeutics Provides Corporate Update for Third Quarter and To Date 2023

GlobeNewswire Inc.

Qualigen Therapeutics Announces First Patient Dosed in the Phase 1a Clinical Trial of QN-302 for Treatment of Advanced or Metastatic Solid Tumors

GlobeNewswire Inc.

Qualigen Therapeutics Inc Azioni (QLGN) Dati Finanziari